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Abstract 
Study of Parameter Estimation and Model Calibration using Bayesian 
Analysis of Noisy Data for a Virus Model 
 
Alejandro Mejia 
 
Numerous engineering problems are concerned with the challenge of representing real life systems 
through mathematical equations: modeling. Properly generated mathematical models can accurately 
predict the behavior of natural processes. The key objective of model development is to correctly 
build a set of equations or expressions that can reproduce the results observed from experimental 
measurements. By following this methodology, sources of error and uncertainty will arise as most 
natural processes have random factors that make the results stochastic, and therefore can never be 
exactly reproduced. A model can try to best approximate the actual outcome, but many times 
assumptions or simplifications are needed because either the problem becomes mathematically 
unfeasible, or there is not enough knowledge regarding the process. Additionally, even if models are 
correctly defined, they may require proper calibration of its parameters to make predictions.  
In the study of virology, within host viral infections can be modeled by means of 
mathematical balances of target cell populations. A virus model will describe how a virus infects 
healthy cells and spreads by defining a set of depletion/replenishment rate parameters that will depend 
on each system. The focus of this study is to determine the posterior probability distributions of these 
parameters that will best approximate a given patient’s data, similar to data fitting. Using an inverse 
modeling approach to generate patient data using known reference values of the virus model 
parameters and adding random “white” noise, a virus model will be fitted to the generated noisy data 
using Bayesian methods for parameter estimation. 
The main purpose of this study is to validate the use of Bayesian calibration techniques as an 
alternative to conventional gradient-based parameter estimation methods. The results of a calibrated 
virus model with a fixed virus generation rate are then used to make model predictions and extrapolate 
the dynamic behavior to different ranges of the fixed parameter. The results conclude that Bayesian 
methods can be successfully used for parameter estimation, especially for high-dimensional 
problems, however the practical identifiability of the parameters is limited by the model’s nonlinear 
terms, the experimental data variance, and the available data measurements. Although the results are 
encouraging, the excessive computation time needed for obtaining the empirical parameter Posterior 
distributions limit the practical use of these methods.  
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Chapter 1  
Introduction 
Mathematical modeling is a useful tool for describing real life processes and systems. If properly 
defined, it can provide valuable results from precise equations that approximate and predict a system’s 
behavior. Modeling is used in many fields of study and areas of research; thus understanding its 
fundamentals is an important skill, especially for modern engineering. With the continuing 
development of computers and more advanced computational software, there is an increasing use of 
numerical methods to model and analyze progressively more complex systems by taking advantage 
of better computational speed and power. This has opened a doorway to the ongoing expansion of 
new methods and techniques of numerically modeling physical systems.  
 
Although modeling can be a powerful tool, it is not without limitations and caveats that must 
be considered to avoid invalid results and conclusions. Although the study of modeling limitations is 
not the main interest of this study, one of the challenges that is discussed in this thesis is the issue 
related to the implementation of a numerical solver for model calibration. Once a mathematical model 
is properly defined, there is usually a concern regarding model calibration that will allow the properly 
calibrated model to predict, under given conditions, future system behavior. This ability to make 
accurate predictions is one of the key advantages of correctly modeling a system. 
 
For the purpose of this research, model calibration refers to the process of determining the 
unknown parameters of a dynamic mathematical model using experimental data, so-called inverse 
modeling or data fitting. The calibrated model represents a function that describes the behavior of the 
system that best approximates the numerical results to the actual measured data, and can be used to 
make predictions. A wide variety of methods exist for calibrating computer models, however, in 
recent years Bayesian analysis has gained much interest in its implementation for statistical inference, 
allowing the making of accurate predictions and informed decisions by employing probability 
distributions [1]. 
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With this in mind, the focus of this thesis is to develop and analyze the implementation of a 
computer-based Bayesian calibration routine for an existing mathematical model. The model chosen 
for testing the calibration code is a simple dynamic virus model that has been used in many studies 
(Gumel et al. [2], Nowak and May [3]) to replicate the initial phase of a virus infection. Although the 
calibration tool may be adapted to other dynamic systems and engineering problems, this model is 
used because it is a known existing mathematical model used in the biomedical/pharmaceutical 
industry and the experimental data set can be obtained from existing patient records if real life 
implementation is anticipated. This model was also initially provided as a test case from PSE’s 
gPROMS® ModelBuilder platform to determine if this commercial advance process modeling 
software could potentially take advantage of an existing Bayesian calibration routine through the use 
of a Foreign Process Interface communication. 
 
The main purpose of implementing a Foreign Process Interface (FPI) is to have gPROMS® 
be the model solver, which reads a parameter set as an input, and deliver an output containing the 
model’s measured virus which could be calibrated to a single infected patient data-set. The output 
from gPROMS® would be used by the calibration routine to explore the parameter space and get a 
posterior distribution. This methodology was only used to test the FPI and the feasibility of 
implementing a calibration tool because the extensive computation time required for every iteration 
makes the Bayesian tool impractical. Because of this undesired model evaluation time, an 
independent C++ version of the virus model solver is also developed to produce the same output and 
reduce the overall calibration time. 
 
1.1 Background and Previous Research on Virus Modeling 
In clinical research, epidemiology refers to the study of how diseases, and their symptoms, can spread 
within populations of individuals. In this sense, the dynamics of a disease spreading is examined on 
a large population scale. When studying viruses, research is also aimed at learning how an 
individual’s system behaves after becoming infected. This within host cell-to-cell infectious micro 
scale spreading phenomenon is of high interest in determining the characteristics of currently known 
viruses, and help study new ones after they are discovered [3]. 
  
 Viruses have been studied for many years, and with extensive investigation, some have even 
been successfully vaccinated against. There is still ongoing research and development in this field. 
The main goal of understanding virus behavior and its process of replicating is to minimize its ability 
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to spread within susceptible populations and effectively reduce or inhibit its adverse effects inside 
individual hosts. Once a virus vaccine is successfully developed, it can be used to assist the patient’s 
immunological system in defending itself from future infection by identifying the foreign infectious 
agent.  
 
 One of the viruses of high concern in recent years, since its discovery in 1981, is the Human 
Immunodeficiency Virus (HIV). The HIV infection attacks the host’s immunological system and is 
characterized by three distinct phases: the primary or acute infection phase, the asymptotic latency 
phase, and the final progression into acquired immunodeficiency syndrome (AIDS). The primary 
phase is identified by the early initial period after infection, where a rapid exponential increase in 
viral load occurs until reaching a maximum peak. The time of HIV primary infection varies greatly 
from patient to patient, but is usually observed in a period of a few weeks, where symptoms may be 
present. After the primary phase reaches its peak viral load, the total virus count decreases gradually 
and settles on a quasi-steady-state viral load that differs for each patient. This phase can last for 
several years, sometimes without showing symptoms or significant detection, and eventually depletes 
the host’s population of healthy target helper T-cells to a critical level, developing into AIDS.  
 
 
Figure 1-1 HIV primary phase infection progression 
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Mathematical modeling of HIV virus dynamics has been centered on the primary phase 
(Murray et al. [4], Tuckwell and LeCorfec [5], Stafford et al. [6]) and most studies are focused in 
attempting to reproduce the various patient behavior after initial infection occurs (see Figure 1-1). 
The target limited virus model used in these studies of primary HIV infection has six rate parameters 
[𝑎 𝛽 𝑑 𝑘 𝜆 𝑢]  as shown in Figure 1-2, taken from the reference textbook (Nowak and May [3]). 
 
 
Figure 1-2 HIV target limited virus model 
 
The currently existing virus models can be used for HIV progression studies by adjusting the 
different rate parameters to cover a wide range of patient immunological responses. Ciupe et al. [7] 
attempt to estimate the kinetic parameters of a target cell limited model and replicate the oscillating 
behavior observed in patients during the primary phase, that are not reproducible by the basic model 
configuration. The exact moment of infection is rarely known, and similarly, the time until the T-cells 
become activated and respond to the virus infection. In their study, a time delay is added to the model 
as an additional parameter to account for the host immune system response. Leenheer and Smith [8] 
use this additional time delay parameter to represent an immune system response that can properly 
model oscillations that are sometimes observed in patients. 
 
1.2 Virus Model Parameter Identifiability 
One of the common challenges found in previous HIV mathematical model studies is the issue related 
to parameter identifiability. Regardless of the model used, previous authors (Xia and Moog [9], 
Wentworth et al. [10], Wu et al. [11]) noted that using measured virus data alone makes the identifiability 
of all the model parameters mathematically achievable, but difficult in practice due to the patient data 
being characteristically noisy. Moreover, other studies (Burg et al. [12]) concluded that using patient 
data from the asymptotic phase of infection makes parameter identifiability and estimation 
impossible. A generally adopted solution for this virus progression measurement constraint is to 
perturb the host dynamics by introducing HIV viral treatment that inhibits the virus replication and 
thus generates a disturbance in the quasi-steady-state virus balance found in the asymptotic phase. 
This approach relies on taking samples after treatment is introduced and finding the parameters from 
the data obtained. 
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 Sensitivity analyses for parameter identifiability have shown that depending on the 
experimental data available, some of the parameters are difficult to identify individually. Soetaert and 
Petzoldt [13] analyze the identifiability of the different combinations of five parameters for a six-
parameter HIV virus model, noting in their study that the parameter set [𝑎 𝛽 𝑑 𝜆 𝑢] has the lowest 
collinearity, and is therefore easiest to identify. Table 1-1 shows the sensitivity analysis results from 
Stoetaert and Petzoldt for the possible parameter combinations, noting that the identifiability of the 
parameters is possible using both measurements of virus particles and cell populations. 
 
Table 1-1 Model parameter collinearity  
 𝑎 𝛽 𝑑 𝑘 𝜆 𝑢 N collinearity 
1 1 1 1 1 1 0 5 41 
2 1 1 1 1 0 1 5 51 
3 1 1 1 0 1 1 5 12 
4 1 1 0 1 1 1 5 34 
5 1 0 1 1 1 1 5 36 
6 0 1 1 1 1 1 5 15 
7 1 1 1 1 1 1 6 53 
* Data obtained from Stoetaert and Petzoldt [13] 
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Chapter 2  
Virus Model 
Viruses are understood as infectious, microscopic particles that contain genetic material (RNA or 
DNA) and need living cells found in organisms in order to “infect” their nucleus and replicate 
themselves. Because a virus cannot reproduce outside of a host cell it is debated whether it should be 
considered as a living or non-living organism. Virology, the study of viruses and their life cycles, 
attempts to understand virus behavior. The theoretical modeling of viral behavior is mathematically 
analogous to the dynamics and survival of a prey-predator population. 
 
2.1 Mathematical Virus Model 
In studying the dynamics of a virus, a basic mathematical model is established which has three state 
variables for each type of population present: the number of uninfected cells (𝑥), the number of 
infected cells (𝑦), and the measure of free virus particles (𝑣). As previously mentioned, there are six 
rate parameters that are used to help describe the relationship between these state variables and model 
the time lapse for each variable, once an initial infection has occurred. The following figure shows a 
diagram depicting the relationship between each of the time dependent variables 𝑥, 𝑦, and 𝑣, with the 
inbound/outbound arrows representing source and sink terms, respectively. 
 
 
Figure 2-1 Illustration of the dynamics of a basic virus model 
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Intuitively a virus infection can be regarded as a dynamic process (see Figure 2-1) where an 
uninfected cell population system, initially at rest, or likewise at equilibrium, is disturbed by an 
infection from an arbitrary amount of virus particles. Once infected, the system will undergo changes 
in the infected/uninfected cell populations due to the creation (replication) and destruction of virus 
particles, also known as virions, and its original cell population dynamics. In other words, the system 
has an initial uninfected cell population balance, which will be altered once an infection is present. 
This new infected system will now either return to a state of equilibrium with the infection and death 
rates leading to the virus particles dying out, or to the continuous growth and eventual overflow of 
infected cells and virus particles. The outcome of this chain reaction will ultimately depend on the 
characteristics of the virus which infects the system. For a given virus, the dimensionless ratio known 
as the reproductive ratio of infection (𝑅0) will determine how the system will behave in time. A 
reproductive ration less than one means that, on average, every virus particle produces less than one 
new virus particle and therefore, in future time generations, the virus count will gradually decrease 
and be eliminated from the system. If instead 𝑅0 is greater than one, the virus will continuously 
produce more new virus particles. The reproductive ratio of infection is an important characteristic 
of infections, and usually of high interest because it gives an idea of how infectious a disease or virus 
can be.  
 
In an uninfected patient, both 𝑦 and 𝑣 are zero. However, when a patient is infected with any 
amount of virus particles, 𝑣0, the uninfected cells become infected with an infection rate which is 
proportional to the product of the variables 𝑥 (number of uninfected cells) and 𝑣 (number of free 
viruses): 𝜷𝑥𝑣. Next, the recently infected cells produce new free virus particles at a rate 𝒌𝑦. The 
uninfected and infected cells each die with a death rate of 𝒅𝑥 and 𝒂𝑦, respectively. Also, the free 
virus particles die or are removed from the system at a rate 𝒖𝑣. In modeling an uninfected cell’s 
dynamics, it is assumed that new cells are generated at a constant rate 𝝀. Alternatively, some authors 
model this replenishment rate of new cells, 𝜆, as a time-varying parameter. For a constant 𝜆 and if no 
virus infection is present, the differential equation that models the uninfected cell population in a 
system is given as follows:  
 
𝑑𝑥
𝑑𝑡
= ?̇? = 𝝀 − 𝒅𝑥 (1) 
It can be shown from this linear ODE that an uninfected system will equilibrate to the steady 
state value 𝑥 = 𝜆/𝑑 that balances the replication and death of uninfected cells in a system. These 
relationships, which can be viewed as source and sink terms, provide the basis for the mathematical 
setup of the virus target cell-limited model as follows: 
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𝑑𝑥
𝑑𝑡
= ?̇? = 𝝀 − 𝒅𝑥 − 𝜷𝑥𝑣 (2) 
 
𝑑𝑦
𝑑𝑡
= ?̇? = 𝜷𝑥𝑣 − 𝒂𝑦 (3) 
 
𝑑𝑣
𝑑𝑡
= ?̇? = 𝒌𝑦 − 𝒖𝑣 (4) 
 These three equations are used to model the time-dependent interaction of a virus infection 
in a system. Hundreds of viruses are currently known to exist and infect living organisms such as 
humans, animals, plants, and bacteria. The Human Immunodeficiency Virus (HIV) is one example of 
a virus which is modeled using these equations. Table 2-1 provides a summary of the parameters used 
to model the virus behavior, and a set of reference values for HIV from a virus dynamics reference 
textbook [3]. 
 
Table 2-1 Virus model HIV parameter values 
Parameter Description Symbol HIV model* Bounds S.D. 
Death rate of infected cells 𝑎 0.5 [0.0 1.0] 0.1 
Virus infection rate 𝛽 2*10-7 [10-9 10-3] 1*10-5 
Death rate uninfected cells 𝑑 0.1 [0.001 0.8] 0.01 
Free virions generation rate 𝑘 100 [0 1000] 1 
New cells replenishment rate 𝜆 1*105 [100 106] 5*103 
Virus death rate 𝑢 5 [1 100] 2.5 
* Values obtained for a reference HIV model from Nowak et al [3] 
 
From these expressions, it is convenient to mathematically define and calculate the 
reproductive ratio of infection as follows: 
 𝑅0 =
𝜆𝛽𝑘
𝑑𝑎𝑢
 (5) 
 For the reference values used in Table 2-1, the reproductive ratio of infection for HIV is 
computed as 𝑅0 = 8. Equations (2), (3), and (4) will be referred to in the remainder of this text, as 
the Bayesian MCMC calibration tool will be used to estimate the five of the six unknown rate 
parameters. For a given initial viral load 𝑣0, the system of equations can be numerically solved using 
a discretization method which will be discussed in the following section. 
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2.2 Numerical Discretization and Model Solver 
The method selected to discretize and numerically approximate (solve) the virus model differential 
equations is an implicit Crank-Nicolson scheme, which provides a stable second-order convergence 
in time stencil. In their studies, Ciupe et al. [7] use a modified Runge-Kutta (RK) method with a step 
size ∆𝑡 = 0.01. Alternatively, Gumel et al [2] propose a faster Gauss-Seidel-like method for this same 
virus model and compare its stability to an RK2 method, showing that this “implicit” discretization 
scheme can also be used. As will be mentioned later, this first-order accurate solution greatly reduces 
the computation time needed. Similarly, an Euler method was initially tested in this study, but not 
used for calibration because of the inherent stability issues of this scheme. The selected method for 
solving the PDEs is shown, where the superscript n indicates the time iteration as follows: 
 
𝑑𝑢
𝑑𝑡
=
𝑢𝑛+1 − 𝑢𝑛
Δ𝑡
=
1
2
[𝐹𝑛+1 + 𝐹𝑛] (6) 
A stencil for the Crank-Nicolson discretization scheme is presented in Figure 2-2. 
 
 
Figure 2-2 Crank-Nicolson discretization method stencil 
 
 Applying this stencil to equations (2), (3), and (4) we obtain the following set of discretized 
equations: 
 
𝑥𝑛+1 − 𝑥𝑛
Δ𝑡
= 𝜆 −
𝑑
2
(𝑥𝑛+1 + 𝑥𝑛) −
𝛽
2
(𝑥𝑛+1𝑣𝑛+1 + 𝑥𝑛𝑣𝑛) (7) 
 
𝑦𝑛+1 − 𝑦𝑛
Δ𝑡
=
𝛽
2
(𝑥𝑛+1𝑣𝑛+1 + 𝑥𝑛𝑣𝑛) −
𝑎
2
(𝑦𝑛+1 + 𝑦𝑛)        (8) 
 
𝑣𝑛+1 − 𝑣𝑛
Δ𝑡
=
𝑘
2
(𝑦𝑛+1 + 𝑦𝑛) −
𝑢
2
(𝑣𝑛+1 + 𝑣𝑛)                      (9) 
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To numerically solve these equations, a Newton-Raphson root-finding solver is implemented 
by moving all the terms to one side and equating each expression to zero. The Newton solver will 
provide a method of iteratively converging to the roots of these equations for each time step Δ𝑡. In 
order to implement this solver using a computer-based algorithm, the inputs are specified as vectors. 
Additionally, a Jacobian matrix is required to compute the partial derivatives of the equations with 
respect to each state variable.  
 
The three discretized equations above are rewritten so that the virus model can be expressed 
in matrix form: 
 0 = 𝑥𝑛 − 𝑥𝑛+1 + Δ𝑡 [𝜆 −
𝑑
2
(𝑥𝑛+1 + 𝑥𝑛) −
𝛽
2
(𝑥𝑛+1𝑣𝑛+1 + 𝑥𝑛𝑣𝑛)] (10) 
 0 = 𝑦𝑛 − 𝑦𝑛+1 + Δ𝑡 [
𝛽
2
(𝑥𝑛+1𝑣𝑛+1 + 𝑥𝑛𝑣𝑛) −
𝑎
2
(𝑦𝑛+1 + 𝑦𝑛)]        (11) 
 0 = 𝑣𝑛 − 𝑣𝑛+1 + Δ𝑡 [
𝑘
2
(𝑦𝑛+1 + 𝑦𝑛) −
𝑢
2
(𝑣𝑛+1 + 𝑣𝑛)]                      (12) 
These expressions are now combined as a vector function 𝐹(?̅?), where ?̅? is a 3x1 column 
vector and the entries correspond to each state variable at the iteration 𝑛 + 1: 
 𝐹(?̅?) = 𝐹 (
 𝑥𝑛+1
 𝑦𝑛+1
 𝑣𝑛+1
) (13) 
 The vector function of inputs 𝑥, 𝑦, and 𝑣 evaluates the virus model balance equations for a 
new time iteration (𝑛 + 1), knowing the previous state (𝑛), the time step, and the corresponding 
parameter values: 
 𝐹(?̅?) =
(
 
 
 
𝑥𝑛 − 𝑥𝑛+1 + Δ𝑡 [𝜆 −
𝑑
2
(𝑥𝑛+1 + 𝑥𝑛) −
𝛽
2
(𝑥𝑛+1𝑣𝑛+1 + 𝑥𝑛𝑣𝑛)] 
𝑦𝑛 − 𝑦𝑛+1 + Δ𝑡 [
𝛽
2
(𝑥𝑛+1𝑣𝑛+1 + 𝑥𝑛𝑣𝑛) −
𝑎
2
(𝑦𝑛+1 + 𝑦𝑛)]         
𝑣𝑛 − 𝑣𝑛+1 + Δ𝑡 [
𝑘
2
(𝑦𝑛+1 + 𝑦𝑛) −
𝑢
2
(𝑣𝑛+1 + 𝑣𝑛)]                      )
 
 
 
 (14) 
The Jacobian matrix 𝐹′(?̅?) for this function is computed by taking the derivative of each 
equation with respect to the state variables at the next iteration n+1: 
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 𝐹′(?̅?) =
(
 
 
 
 
𝜕𝐹1(?̅?)
𝜕𝑥𝑛+1
𝜕𝐹1(?̅?)
𝜕𝑦𝑛+1
𝜕𝐹1(?̅?)
𝜕𝑣𝑛+1
𝜕𝐹2(?̅?)
𝜕𝑥𝑛+1
𝜕𝐹2(?̅?)
𝜕𝑦𝑛+1
𝜕𝐹2(?̅?)
𝜕𝑣𝑛+1
𝜕𝐹3(?̅?)
𝜕𝑥𝑛+1
𝜕𝐹3(?̅?)
𝜕𝑦𝑛+1
𝜕𝐹3(?̅?)
𝜕𝑣𝑛+1 )
 
 
 
 
 (15) 
Where 𝐹𝑖(?̅?) is the corresponding row (equation) of the vector function 𝐹(?̅?) for 𝑖 = 1, 2, 3. 
 𝐹′(?̅?) =
(
 
 
 
−1 − ∆𝑡 (
𝑑
2
+
𝛽
2
𝑣𝑛+1) 0 −∆𝑡
𝛽
2
𝑥𝑛+1 
∆𝑡
𝛽
2
𝑣𝑛+1 −1 − ∆𝑡
𝑎
2
∆𝑡
𝛽
2
𝑥𝑛+1 
0 ∆𝑡
𝑘
2
−1 − Δ𝑡
𝑢
2
 )
 
 
 
 (16) 
 The Newton-Raphson method for finding the roots to the vector function 𝐹(?̅?) is defined as 
follows: 
 𝑥𝑘+1
𝑛+1 = 𝑥𝑘
𝑛+1 − [𝐹′(𝑥𝑘
𝑛+1)]
−1
𝐹(𝑥𝑘
𝑛+1) (17) 
Where the 𝑘 subscript specifies the Newton iteration, [𝐹′(𝑥𝑘
𝑛+1)]
−1
 is the inverse of the 
Jacobian matrix, and 𝑥𝑘
𝑛+1 is the current solution for the states, given as a vector. 
  
The inverse of the Jacobian must be approximated using some numerical method that is both 
easy to implement and does not use excessive computation time, as it will need to be computed for 
every time step iteration. A simple Jacobi method that decomposes the Jacobian matrix into two 
matrices (diagonal and residual matrices) is used. This numerical method of finding the inverse of a 
matrix is less computationally expensive than an LU decomposition. 
  
 With the matrices and vectors from equations (14) and (16), equation (17) can be evaluated 
and iteratively solved for a given time step ∆𝑡. This process is implemented into C++ as a model 
evaluator for a given virus parameter set input. The algorithm output can be user-defined to assign a 
vector that contains the measured virus in a time interval that matches the experimental patient data. 
This method is tested with a working virus model in the gPROMS ModelBuilder® environment to 
verify that no coding error exists. The Crank Nicolson (C-N) finite difference numerical solver was 
implemented for correctly running the C++ based MCMC routine. Afterwards, a Gauss Seidel-like 
(GSS) method proposed by Gumel et al. [2] was found to have fast, stable, and accurate computational 
results, and eventually used for the final stage of this study, after initial results from the C-N algorithm 
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were obtained. The time derivative is approximated using a first-order forward-difference numerical 
scheme as follows: 
 
(𝑥𝑛+1 − 𝑥𝑛)
∆𝑡
= λ − 𝑑𝑥𝑛+1 − 𝛽𝑥𝑛+1𝑣𝑛 (18) 
 
(𝑦𝑛+1 − 𝑦𝑛)
∆𝑡
= 𝛽𝑥𝑛+1𝑣𝑛 − 𝑎𝑦𝑛+1        (19) 
 
(𝑣𝑛+1 − 𝑣𝑛)
∆𝑡
= 𝑘𝑦𝑛+1 − 𝑢𝑣𝑛+1              (20) 
 These expressions can be re-arranged to leave the unknown iteration in terms of the known 
current states to give the following explicit linear algebraic system: 
 𝑥𝑛+1 =
𝑥𝑛 + ∆𝑡 ∙ λ
1 + ∆𝑡(𝑑 + 𝛽𝑣𝑛)
    (21) 
 𝑦𝑛+1 =
𝑦𝑛 + ∆𝑡 ∙ 𝛽𝑥𝑛+1𝑣𝑛
1 + ∆𝑡 ∙ 𝑎
 (22) 
 𝑣𝑛+1 =
𝑣𝑛 + ∆𝑡 ∙ 𝑘𝑦𝑛+1
1 + ∆𝑡 ∙ 𝑢
      (23) 
 The virus model is solved using both the C-N and GSS methods discussed in this chapter, but 
the latter provides faster MCMC steps by omitting the need to compute the inverse of the Jacobian 
and will be used to produce the final results for the Bayesian calibration. The next chapter will discuss 
the fundamentals of Bayesian analysis needed to understand how the MCMC calibration tool will be 
used for analyzing a noisy patient data set and estimate the parameters for the HIV virus model. 
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Chapter 3  
Bayesian Model Calibration 
When calibrating a mathematical model, the main goal is to determine the unknown parameters in 
the model equations using measured experimental data, so-called data fitting. The measured data 
provides the necessary information to compare model output against. Many techniques exist for 
model calibration, such as Maximum Likelihood Estimation (MLE) and Least Squares (LS) based 
estimation. An alternative approach to getting model parameter estimations is through the use of 
Bayesian analysis, where the unknown parameters are defined as random variables and given a 
probability distribution, which represents degree of belief for the true parameter values. Bayesian 
model calibration is implemented using Bayes theorem for conditional probabilities. 
 
3.1 Fundamental Statistics and Bayes’ Theorem 
Statistics is the discipline that focuses on collecting, organizing, presenting, and analyzing data that 
is generally gathered from experiments. One main branch of statistics is probability theory, which 
deals with the analysis of random experiments or events. From probability theory, the conditional 
probability of an event 𝐴 occurring given that another event 𝐵 has occurred is stated by: 
 𝑃(𝐴|𝐵) =
𝑃(𝐴⋂𝐵)
𝑃(𝐵)
 (24) 
Figure 3-1 shows this concept graphically with a Venn diagram. Here, the sample space 𝒞 contains 
all possible outcomes of a random experiment, where events 𝐴 and 𝐵 each have a corresponding 
probability not equal to zero. The conditional probability of an event can be viewed as an event that 
occurs within a new sample space given by the conditional event. Therefore, the conditional 
probability of 𝐴 given 𝐵, mathematically expressed as 𝑃(𝐴|𝐵), is the darker shaded region, where 
event 𝐵 has already occurred and thus becomes the new sample space. Also from this diagram, it can 
be seen that the probability of event 𝐴 occurring is equivalently expressed in terms of event 𝐵 as:  
 𝑃(𝐴) = 𝑃(𝐴⋂𝐵) ⋃ 𝑃(𝐴⋂𝐵′) (25) 
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Figure 3-1 Conditional probability of two intersecting sets 
 
We are interested in the events where both 𝐴 and 𝐵 have occurred. In other words the 
intersection of these events. From this notion, we can directly identify the conditional probability. 
Now, redistributing equation (24), we obtain the Multiplication Rule of Probability, which states that 
the probability of two events 𝐴 and 𝐵 occurring (intersection) is equal to the probability of one event 
occurring, 𝑃(𝐴), times the conditional probability of the other event 𝐵 occurring given that the first 
event 𝐴 occurred, 𝑃(𝐵|𝐴), and vice versa:  
 𝑃(𝐴⋂𝐵) = 𝑃(𝐴) 𝑃(𝐵|𝐴) (26) 
 𝑃(𝐵⋂𝐴) = 𝑃(𝐵) 𝑃(𝐴|𝐵) (27) 
Since the intersection of sets has Commutative properties, equations (26) and (27) are equal 
and can be combined to express the following: 
 𝑃(𝐴) 𝑃(𝐵|𝐴) = 𝑃(𝐵) 𝑃(𝐴|𝐵) (28) 
Bayes’ theorem immediately follows from this expression and states the probability of an 
event occurring, given prior information related to the conditional event. Mathematically Bayes’ rule 
is stated as follows: 
 𝑃(𝐴|𝐵) =
𝑃(𝐵|𝐴) 𝑃(𝐴)
𝑃(𝐵)
 (29) 
Where A and B are two random events with probabilities 𝑃(𝐴) and 𝑃(𝐵) ≠ 0, respectively. 
𝑃(𝐴|𝐵) is the conditional probability of observing event 𝐴 given that 𝐵 has occurred, and similarly 
𝑃(𝐵|𝐴) is the conditional probability of event 𝐵 occurring given that event 𝐴 has occurred. 
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 For the purpose of Bayesian calibration of mathematical models, event 𝐴 is defined as an 
arbitrary parameter set 𝜃 (usually a vector) and 𝐵 is the given experimental data set 𝑍. Therefore, the 
conditional probability 𝑃(𝐴|𝐵), or from here on 𝑃(𝜃|𝑍), is defined as the probability of a particular 
parameter set being the true values of the model, given that the specific data set 𝑍 is observed. In any 
multidimensional parameter space, this conditional probability has an unknown distribution and is 
referred to as the Posterior distribution (𝛱). The Posterior distribution is the desired result of the 
Bayesian calibration. Furthermore, the conditional probability 𝑃(𝑍|𝜃) is the probability that the 
experimental data set 𝑌 is observed given that the parameter set 𝜃 is the true value. This term is also 
known as the Likelihood (ℒ). Correspondingly, 𝑃(𝜃), which is the simply the probability of any 
parameter set being observed from the entire parameter space, is referred to as the Prior probability 
and it represents the observer’s belief of a certain parameter set being true prior to any data 
information being taken into account. Finally, the term 𝑃(𝑍) can be expressed using the Law of Total 
Probability for a continuous random vector and it is computed as the following integral: 
 𝑃(𝑍) = ∫𝑃(𝑍|𝜃) 𝑃(𝜃)
.
𝜃
𝑑𝜃 (30) 
 The integral in equation (30), also known as the marginal likelihood, is often very difficult to 
evaluate, especially if there are many parameters (high-dimensional integration). However, the 
probability is only dependent on the observed data 𝑍 and is the same for every possible parameter set 
𝜃. Thus, Bayes’ theorem (29) can be used to obtain the Posterior distribution, with the integral being 
only a normalizing factor or constant, thereby giving a proportional relation as follows: 
 𝑃(𝜃|𝑍) ∝ 𝑃(𝑍|𝜃) 𝑃(𝜃) (31) 
Expressing the Posterior distribution as 𝛱, the Likelihood function as ℒ, and including the 
observational error variance (𝜓) as an additional unknown parameter for the calibration, we get the 
following useful expression: 
 𝛱(𝜃, 𝜓|𝑍) ∝ ℒ(𝑍|𝜃, 𝜓) 𝑃(𝜃) 𝑃(𝜓) (32) 
Using this notation, the data set 𝑍 is assumed to have an observational error, and the model 
is regarded as being a perfect representation of the actual process. This observational error (𝜖) has a 
normal (Gaussian) distribution with mean zero and variance 𝜓, also known as “white noise”. Thus, 
the errors can be expressed as the difference between the measured data and the “true” model values: 
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 𝜖𝑖 = 𝑧𝑖 − ?̃?𝑖 ∼ 𝑁(0, 𝜓) (33) 
Furthermore, the Likelihood can be computed from these independent and identically 
distributed (I.I.D.) observational errors using the joint pdf of 𝑛 samples from a Normally distributed 
random variable: 
 ℒ(𝑍|𝜃,𝜓) =∏
1
√2𝜋 𝜓1 2⁄
𝑛
𝑖=1
𝑒
[−
1
2
(𝑧𝑖−?̃?𝑖)
2
𝜓 ] (34) 
The Likelihood cost function can equivalently be rewritten in terms of the sum of squared 
error (𝑆𝑆𝑞) as: 
 ℒ(𝑍|𝜃, 𝜓) = (2𝜋𝜓)−𝑛/2 ∙ 𝑒
[
−𝑆𝑆𝑞
2𝜓 ] 
(35) 
 𝑆𝑆𝑞 =∑(𝑧𝑖 − ?̃?𝑖)
2
𝑛
𝑖=1
=∑𝜖𝑖
2
𝑛
𝑖=1
 (36) 
Observing these equations, it is evident that the Likelihood for any proposed model will 
increase as the sum of squared error term decreases, which is exactly what is anticipated as it should 
provide a measure of closeness between the proposed model and the measurement data.  
 
Defining the remaining term, 𝑃(𝜃), is an initial assumed distribution for the parameter set 𝜃. 
Thus, one of the important aspects of Bayesian calibration is the selection of the prior distribution. 
Whenever certain information is known beforehand, it can be included in the calibration by means of 
the prior. If there is no information or knowledge about the parameter values, an uninformative prior 
is used and recommended, as an incorrect prior can have negative impact on the actual Posterior. This 
uninformative prior is specified by using a uniform distribution across the continuous parameter 
space, where every possible outcome is equally likely (see Figure 3-2): 
  𝑃(𝜃) ~𝑈(𝐴, 𝐵) (37) 
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Figure 3-2 Uninformative prior for a parameter with bounds [A,B] 
 
Lastly, the observational error variance 𝜓 has an Inverse Gamma prior distribution, with 
observational shape (𝜈) and rate (𝜏) parameters:  
  𝑃(𝜓) ~Inv-gamma(𝜈, 𝜏) (38) 
 
Figure 3-3 Inverse Gamma PDF 
 
The Inverse Gamma distribution is often used for Bayesian inference because of the 
convenient property of being a conjugate prior distribution (posterior and prior distributions are from 
the same family) to a Gaussian “white noise” likelihood function. This conjugate property allows for 
direct sampling from the conditional posterior for the observational error variance without rejection. 
 
Now that Bayes’ theorem provides a method of updating the Posterior distribution for an 
arbitrary point or parameter set, it is necessary to have a technique that allows for the exploration of 
the parameter space and after a certain amount of iterations approximate the posterior probability 
distribution. One sampling method for exploring the parameter space is through the use of a Markov 
chain Monte Carlo (MCMC) algorithm.  
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3.2 Markov chain Monte Carlo 
In Bayesian calibration, a Markov chain Monte Carlo is a method of iteratively sampling from a 
probability distribution, and constructing a sample distribution that will represent the target posterior 
distribution. It provides an organized procedure for searching the parameter space for regions of 
higher Likelihood. The idea is that the Markov process will reach an equilibrium distribution that is 
a sample drawn from a simulation of the posterior distribution. The routine will begin at an initial 
parameter space starting point from which it will propose new parameter sets and evaluate their 
likelihood. If a proposed parameter set (𝜃1) has a higher likelihood than the current parameter point 
(𝜃0), then the chain will move to this new region or point in the parameter space. If the proposed point 
has a lower likelihood, then the algorithm will either reject the new set or accept it, with a certain 
probability, compared to a random draw from a Normal(0,1) distribution. This acceptance criteria is 
defined using the following acceptance ratio, which is computed every MCMC iteration: 
 𝑟(𝜃1|𝜃0) =
ℒ(𝑌|𝜃1, 𝜓1) 𝑃(𝜃1) 𝑃(𝜓1)
ℒ(𝑌|𝜃0, 𝜓0) 𝑃(𝜃0) 𝑃(𝜓0)
 (39) 
 𝜃 = {
𝜃1, with probability 𝑝 = min (1, 𝑟)
𝜃0, else
 (40) 
The Likelihood ratio is usually calculated in logarithmic scale, as the terms can quite often 
be very small. Additionally, the MCMC routine has an adaptive proposal option, which uses an 
empirical covariance matrix for the proposal distribution that is calculated from previously accepted 
states. Using only a certain number of prior states to calculate the covariance matrix, a fixed window 
is obtained. This adaptive proposal tool is subsequently used to increase/decrease the proposal step 
size in order to achieve a desired target acceptance rate. The specification of a target acceptance rate 
allows for the MCMC to avoid high acceptance/rejection rates that can lead to local convergence or 
limited parameter space exploration. 
 
The statistical acceptance of points with lower likelihood allows the MCMC algorithm to step 
out of regions of local maxima/minima. Conceptually a Markov Chain with an infinite number of 
Monte Carlo steps will exactly match the desired Posterior distribution. However, this is clearly not 
possible to implement in real life applications and we can only run the algorithm for a certain amount 
of time. Nevertheless, if the MCMC routine runs for a sufficient number of steps, then an empirical 
probability density function (pdf) can be obtained that will represent a sample from the Posterior. 
Because the algorithm can endlessly continue to take MCMC steps, it is important to specify a 
convergence criteria that can indicate when the routine has obtained sufficient samples. Evidently, 
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there is no single argument to specify when the MCMC has taken a “sufficient” number of samples, 
but a proposed batch means convergence, discussed in the next section, can be used to identify when 
the chain has reached a statistically significant convergence of the parameter means. 
 
3.3  Batch Means Convergence Criteria 
As mentioned in the previous section, an MCMC generates a random walk through the parameter 
space and will continuously take more steps until the algorithm is stopped or it reaches a 
predetermined number of steps. There are two important calibration properties that need to be 
considered for deciding when to stop the algorithm: burn-in and convergence. Burn-in refers to the 
initial region (arbitrary n number of steps) of the MCMC where the chains will be initialized at a 
selected starting point, which can potentially be random, and begin exploring the parameter space. 
These first n samples need to be discarded from the final empirical density distribution. After these n 
steps are taken, the chains will have ideally reached a parameter space region that contains the 
Posterior density and begin taking useful samples. Here an additional convergence condition is 
needed. 
 
 A statistical convergence criterion that can be quickly used to identify when the algorithm 
has successfully sampled the posterior distribution is through a batch means test. This convergence 
criterion will take the remaining 𝑁 − 𝑛 samples, after burn-in, and create equal size bins, or batches. 
Next, each bin’s population mean is computed. The batch means test will determine how these 
estimated means vary and through a Student’s t-test give an indication of average batch means 
convergence with a confidence interval ±𝑝%. A confidence interval of ±1% is ideal, but ±5% is 
also acceptable to reduce the overall simulation time. An arbitrary parameter’s (𝜇) batch means 
confidence interval is estimated as follows: 
 𝜇 = ?̅? ± [(
𝑡(0.975,𝑁 − 1) ∗ ?̅?
√𝑁
) ?̅?⁄ ] ∗ 100% (41) 
 Where 𝑡(∙) is a t-statistic function that tests whether the means of two populations are close 
within a given confidence interval. As the confidence interval becomes smaller, the batch means are 
consequently closer and the chain samples can be regarded as converged. 
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Chapter 4  
Parameter Estimation Methodology 
This chapter outlines the steps involved in performing a parameter estimation through a Bayesian 
analysis approach algorithm using a MCMC to obtain the parameter posterior distributions. For this 
virus model case, a set of generated experimental values are needed for parameter calibration. The 
experimental data set represents measurements taken from an infected patient (usually number of 
virus particles per milliliter of blood) for a useful time interval normally given in a time-lapse of 
either days or months.  
 
4.1 Experimental Data Generation 
Actual patient data is not immediately available for testing the virus model and a technique for 
approximating real life data is desired. Hence, a method of generating the calibration experimental 
data was used. The generated data was obtained by modeling the virus function using a set of standard 
reference HIV parameters (Table 2-1). Additionally, the generated data has added noise to represent 
actual measurement error and variations, typically found in real life measurements, by using the 
following expression: 
 log10 𝑍𝑒𝑥𝑝 = log10 𝑍𝑚𝑜𝑑𝑒𝑙 + 0.5 ∗ 𝑁(0,1) (42) 
This process of adding noise relies on randomly generated values from a Normal distribution. 
Although it is not actual measured data, it has been shown that this type of noisy data can closely 
match actual data obtained from groups of similar patients. Figure 4-1 shows a plot of the model data 
and the “experimental” noisy data. 
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Figure 4-1 Patient data generated using HIV model parameters with added noise 
 
The randomly generated noisy data has been shown to be a realistic representation of the variability 
seen in practice. Some studies have used similar methods of generating noisy virus data, with more 
or less variation. 
 
4.2 Genetic Algorithm for Optimizing MCMC Starting Point 
The MCMC code can be configured to start a run from any point within the parameter space bounds; 
however, random starting points can potentially take too long to properly explore the entire space 
and/or quickly reach a local minimum, especially for multidimensional problems. It is therefore 
desirable to have a means of selecting starting points that can reduce the unwanted effects of using a 
randomly generated starting point. 
 
A basic genetic algorithm implementation, inspired on the natural evolution of species, 
consists of iteratively exposing a group or population of potential solutions (parameter sets), which 
represent individuals, to a user-defined cost or fitness function that represents the environment. The 
main idea is that only the fittest individuals (potential solutions) will “survive” in the specific 
environment and consequently be more likely to reproduce and create new offspring that inherit the 
parent’s good traits through a crossover operator that can randomly combine the parents’ 
chromosomes. In a computer-based GA, a chromosome contains the individual’s “genetic” 
information, or for parameter optimization problems, the actual values for each of the parameters 
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(also referred to as genes). The new populations are also exposed to a mutation operator that ensures 
more randomness in the process by changing one or several genes. After iteratively exposing each 
new generation of individuals to the fitness function, the algorithm will ideally have explored the 
parameter space in search of better fit individuals and eventually reach a population that contains 
many good solutions and no apparent improvement in performance index. 
 
A simple genetic, or evolutionary, algorithm (GA) for minimizing the experimental and 
model data error is implemented to find a starting point that has a dynamic behavior that can closely 
represent the experimental data. The starting point for the MCMC can be an individual selected from 
the final genetic algorithm population based on a performance index provided by the algorithm’s 
fitness function. The performance index selected is a weighted average of four different error 
measurements: maximum error, root mean square deviation (RMSD), sum of squared error, and total 
error. The performance index is assigned in a [0  1] interval, with 1 being a perfect match of the model 
with the data and not actually expected.  
 
The GA routine will generate a user-defined number of random individuals, which represent 
the initial population. As mentioned previously, an individual represents a potential solution, or set 
of model parameters. After an individual is simulated using the virus model numerical solver, a fitness 
function will assign a performance index (PI) to that corresponding set of parameters that will provide 
a measure of the accuracy between the individual’s model output and the experimental data. The 
randomness used in this technique means that a different potential solution will be obtained each time 
the algorithm is ran. Having an initial random seeding spread out across the parameter space and a 
crossover/mutation rate for the population in every generation also gives this method the useful 
algorithm characteristic of potentially avoiding local minima. Ciupe et al. used a similar search 
technique in their estimation of the kinetic parameters [7]. 
 
4.3 MCMC Setup 
The methodology applied in this study uses an adaptive sampler to account for high/low acceptance 
rates of proposed parameters. The adaptive sampler allows the MCMC to explore more locally if the 
acceptance rate is too low and inversely widen the proposal window if the acceptance of new 
parameter sets is too high. Therefore, the user can specify the bounds on the adaptive sampler as well 
as assign a switch to stop the adaptive steps after burn-in. Additionally, the MCMC allows for several 
other user inputs that can improve the overall results and/or calibration time.  
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Some of the MCMC parameters that are user-defined include the model parameter starting 
points, parameter bounds, covariance matrix recalculation rate, adaptive sampling switch, 
observational error shape (𝜈) and rate (𝜏) parameters, and number of desired MCMC steps, which can 
also be replaced with a convergence criteria if available. 
 
This user-defined configuration implies that some knowledge or experience with Bayesian 
calibrating is necessary to correctly tune and obtain good results. An alternative to having expert 
knowledge is to run the MCMC with a predetermined setting to get preliminary results and then retune 
the algorithm configuration parameters appropriately. This is particularly useful for determining 
chain burn-in and identifying when to break the adaptive sampler. Additionally, the MCMC can be 
restarted from the last chain point by inputting the Covariance matrix. This is also useful for resetting 
the Covariance matrix when the chains seem to “flatline” and show slight movement, which is 
visually identified when the chains remain in a narrow range, as shown in Figure 4-2. 
 
 
Figure 4-2 Flatlined parameter chains 
 
The following table provides a layout of the Virus Model MCMC user-defined configuration 
file used for calibrating the model parameters: 
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Table 4-1 MCMC configuration 
MCMC user parameters Default Configuration 
Number of Parameters 6* 
Inv-Gamma Shape Parameters (𝜈) 4 
Inv-Gamma Rate Parameters (𝜏) 5 
Number of MCMC Steps 420,000 
Proposal Type Block 
Covariance Matrix Recalculation Every 4,000 steps 
Dynamic Step Recalculation Rate Every 250 steps 
Adaptive Switch Off After 120,000 steps 
Acceptance Rate Bounds [1  10] 
Log Scale Switch [0 1 0 0 1 0] 
Parameter Bounds/S.D. (see Table 2-1) 
* Five calibration parameters, one fixed 
 
 The parameter proposal type is a convenient user-defined configuration option. The currently 
used “BLOCK” proposal option allows for the MCMC to propose all of the calibration parameters at 
once, as opposed to the “SINGLE” proposal option that only proposes the parameters one at a time. 
Both options have their respective advantages and disadvantages: while the block proposal 
configuration allows the MCMC to take potentially larger steps in the parameter space and reduce the 
total number of model solver iterations, the single proposal will be more likely to produce accepted 
parameter sets at the cost of multiple model evaluations and increased computation time. 
 
From the model described in the previous chapter, the calibration parameter set 𝜃 for the virus 
is given by the following vector: 
 𝜃 = [𝑎, 𝛽, 𝑑, 𝑘, 𝜆, 𝑢]T (43) 
 Additionally, if any parameter is fixed for calibration purposes, then 𝜃 will correspond to the 
remaining unknown parameters. The experimental patient data is also defined as a vector that contains 
the measured virus particles in the patient at certain time intervals: 
   𝑍 = [𝑧1,  𝑧2, … ,  𝑧𝑛]
T (44) 
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 The sampling rate used for running the MCMC is every 0.25 time units. Because the model 
does not have any specific defining time scale, this sampling rate can be scaled to any time interval 
as needed by appropriately adjusting the rate parameter time units. 
 
 Lastly, the initial conditions are input as a vector containing the values for the three state 
variables: 
   ?̅?(𝑡 = 0) = [𝑥(0)  𝑦(0)  𝑣(0)]T (45) 
 In this thesis, constant initial conditions are assumed for the study of one data set, but 
alternatively these conditions can be included as unknown parameters for the MCMC to estimate. 
The initial conditions used in this case are as follows: 
   ?̅?(𝑡 = 0) = [106  0  102]T (46) 
With the parameter vector, model data vector, and initial conditions vector now properly 
defined, the MCMC routine can be setup to run a parameter estimation using the virus model 
numerical solver to evaluate the proposed parameter sets. The following block diagram in Figure 4-3 
shows the general layout of the MCMC algorithm: 
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Figure 4-3 MCMC block diagram 
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Chapter 5  
Results and Discussion 
The focus of this study was to test the results of a Bayesian calibration tool against a maximum 
likelihood analysis currently used in PSE’s gPROMS ModelBuilder® platform. The virus model was 
first tested using this parameter optimization option within the gPROMS interface to compare the 
results obtained from a point estimate technique. 
 
5.1 gPROMS ModelBuilder® Parameter Estimation 
PSE’s advanced process modeling tool gPROMS is a commercially available software commonly 
used to model industrial/chemical processes. Within the gPROMS language environment, the user 
has the option of running a gradient-based parameter estimation for a given mathematical model with 
experimental data. This approach uses a maximum likelihood estimation to provide a point estimate 
that minimizes the observation error (see Figure 5-1). However, this method of estimating model 
parameters has the disadvantage of easily converging to a local minimum, even if a relatively good 
starting point or guess is used. The results from a gPROMS virus model file are shown in Table 5-1 
for estimating all six rate parameters. Notice that some parameters are hitting their bounds. These 
results are not representative of the final MCMC calibration model as this was an initial test of a 
gPROMS parameter estimation capability for the virus model. 
 
Table 5-1 gPROMS ModelBuilder® parameter estimation results 
Parameter Initial Guess gPROMS MLE True Values 
  𝑎   0.20   0.19   0.50 
  log10 𝛽   -7   -6.48   -6.7 
  𝑑   0.05   0.046   0.10 
  𝑘   80   1000   100 
  log10 𝜆   4   2   5 
  𝑢   5   100   5 
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Figure 5-1 gPROMS MLE parameter result 
 
5.2 Genetic Algorithm Starting Points 
The procedure followed in this study for starting the Bayesian calibration is to initially run an 
optimizing genetic algorithm such that a relatively good first set of parameters is found for starting 
the MCMC. The algorithm is designed to give a set of model parameters that provide a dynamic virus 
behavior that closely matches the noisy experimental data. The randomness implied in this process 
and the high dimensionality of the problem mean that each GA optimization produces different 
starting points every time it is executed. The results obtained clearly show the complexity of this six-
parameter model and how several combinations of the input parameters can produce similar dynamic 
response.  
 
Figure 5-2 shows the evolution of a GA run with the blue line representing the performance 
index (PI) of the best individual in the current population while the dashed purple line represents the 
average performance index of the population. By using an elitist approach in the algorithm, the best 
solution in each iteration is guaranteed to survive and continue for at least the next future generation, 
until a better solution is found. This is observed in the performance index GA plot, as the best 
individual performance index is always increasing. For this particular run, the algorithm found a 
solution with a performance index close to 0.9 that indicates that the error fitness function is relatively 
close to the maximum optimal value of one. As a result, the closeness of the best individual to the 
noisy data is fairly decent. 
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Figure 5-2 GA performance index for each generation 
 
 The algorithm’s randomly drawn initial population has few individuals that obtain a good 
performance index, Figure 5-3(a), but as the generations evolve, through crossover and mutation 
operations better solutions are found, Figure 5-3(b), until reaching a final population, Figure 5-3(c), 
that should contain at least one individual with a relatively high performance index. 
 
 
Figure 5-3 GA best individual solutions for initial, intermediate, and final populations 
 
The following table gives the parameter set results for five selected GA simulations that are 
consequently used as starting points for the calibration. Each GA parameter optimization run uses a 
randomly seeded preliminary population with equal probability across the parameter bounds. Since 
the true values used to generate the model are know, it is important to note that the GA provides 
parameter optimization solutions that are relatively close to the desired values. However, as will be 
seen after the Bayesian calibration, this point estimate results do not guarantee that the MCMC will 
a b c 
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remain within these parameter regions. Instead, the MCMC will explore neighboring points, and 
occasionally generate posterior densities in regions different from the initial starting points. 
 
Table 5-2 Selected GA parameter starting points 
Parameter True Value GA#1 GA#2 GA#3 GA#4 GA#5 Mean S.D. 
𝑎 0.50 0.20 0.42 0.322 0.19 0.44 0.31 0.11 
log10 𝛽 -6.70 -7 -6.53 -6.55 -6.41 -6.61 -6.62 0.20 
𝑑 0.10 0.05 0.204 0.065 0.27 0.17 0.152 0.08 
𝑘* 100 100 100 100 100 100 100 0 
log10 𝜆 5 4 5.15 4.65 4.99 5 4.76 0.41 
𝑢 5 15 7.05 7.9 8.77 5.35 8.81 3.01 
* The virus generation rate 𝑘 is fixed at its actual value for calibration 
 
The parameter sets obtained from the GA show the variation of the potential solutions. 
Although the algorithm converges to values that are within one order of magnitude of the true values, 
the noise in the data allows for many possible combinations of the parameters that will have similar 
fitness function values, and thus similar calculated overall error. 
 
5.3 MCMC Results 
The virus model calibration was initially designed to have the gPROMS ModelBuilder® as a model 
solver and use a Foreign Process Interface (FPI) to communicate with the C++ based MCMC 
developed tool using input/output text files. Although this configuration was successfully setup, the 
repetitive use of the virus model solver for every Monte Carlo step made this interface very inefficient 
for calibration purposes. The main disadvantage of this setup was the required authentication of a 
software license request to execute the ModelBuilder® solver  file using an in-built gPROMS 
command: gO:RUN. 
 
The initial FPI results are not shown in this study due to the limited sample sizes that were 
successfully obtained. Instead, the C++ Crank-Nicholson numerical solver was subsequently 
implemented as mentioned in Chapter 2. This new solver implementation reduced the MCMC 
computation time in half, from roughly 1 hour for every one thousand steps with gPROMS to 
approximately 30 minutes. Afterwards, the Gauss-Seidel algorithm further reduced the computation 
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time by 1/10 and ultimately provided 1000 MCMC steps every 3 minutes. This faster model 
computation resulted in the MCMC routine being able to obtain an empirical Posterior distribution 
with 300,000 steps (excluding burn-in) in less than one day. 
 
 After running many calibrations with varied starting points, the results obtained indicated 
multiple MCMC outcomes. The following plots show the parameter chain results for some of the 
selected starting points in Table 5-2 that prove the different parameter coverage. 
 
 
Figure 5-4 MCMC parameter chains for GA#5 
 
 Figure 5-4 shows the result for the parameter chains (blue) for the five calibrated parameters; 
the virus reproduction rate (𝑘) is a fixed parameter, at its reference value. This is observed by the 
fixed line which shows no change in the parameter value as the MCMC progresses.  The red line 
corresponds to the actual parameter values. For this particular calibration result, the uninfected cell 
generation rate 𝜆 is the only parameter that is not covered by the chain after burn-in. As was 
mentioned by Stafford et al. [6], this parameter is not possible to estimate when only using measured 
virus data for parameter estimation and is usually expressed in terms of the initial cell population 
count 𝑥0 and the uninfected cell death rate 𝑑. 
 𝑥0 =
𝜆
𝑑
 (47) 
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Figure 5-5 MCMC variate plots with parameter PDF for GA#5 
 
 As previously discussed, the batch means test for chain convergence was used as a criterion 
to statistically indicate when the MCMC had obtained sufficient samples from the Posterior 
distribution. Table 5-3 shows the batch means test results for the MCMC starting points selected from 
the GA optimization routine given in Table 5-2. 
 
Table 5-3 Parameter batch means for converged calibrations 
Mean (𝜇) GA#1 GA#2 GA#3 GA#4 GA#5 Mean S.D. 
 𝜇𝑎 0.801 0.696 0.529 0.107 0.414 0.509 0.24 
 𝜇𝛽 -6.56 -6.42 -6.46 -6.57 -6.33 -6.47 0.09 
 𝜇𝑑 0.417 0.332 0.178 0.109 0.272 0.262 0.11 
 𝜇𝑘* 100 100 100 100 100 100 0 
 𝜇𝜆 5.30 5.56 5.40 3.32 5.41 4.998 0.84 
 𝜇𝑢 4.59 10.56 11.55 6.99 13.72 9.48 3.27 
* The virus generation rate 𝑘 is fixed at its actual value for calibration 
 
 The batch means values (𝜇) are a measure of each parameter’s population mean for the 
selected number of bins or batches from the total number of MCMC step samples. Each of the 
parameters in Table 5-3 had a confidence interval of 95% or higher.  
 
 Lastly, contour plots (see Figure 5-6) are also plotted for the five calibrated parameters using 
a heatmap color bar to reveal the 2D bivariate regions of higher density, that are not easily identified 
from the monochromatic scatter plots. 
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Figure 5-6 Bivariate contour plots for GA#5 
  
5.4 Model Calibration and Predictions 
In the previous section, the marginal probabilities were plotted to show the empirical Posterior 
densities. These PDFs are samples from the Posterior distribution and as such are used to randomly 
draw sets of parameters that show the coverage of the calibrated model compared to the noisy 
experimental data. Figure 5-7 shows the coverage of the GA#5 data set and the actual model used to 
generate the data that represents what the calibration should obtain when no noise is present. 
 
 
Figure 5-7 Calibrated model coverage over the experimental data 
 
 Figure 5-7 shows 50 randomly selected parameter sets from the calibration Posterior. This 
calibrated model is compared to the noisy patient data and additionally shows the actual model used 
to generate the data. In order to test the calibrated model prediction capabilities for different virus 
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generation rates 𝑘, these randomly picked parameter sets are ran through the solver for 2 different 
user-input values of fixed 𝑘, larger and smaller than the true value used for calibration, to analyze the 
extrapolation capabilities.  
 
 
Figure 5-8 Calibrated model predictions for 𝑘 = 50 
 
 
Figure 5-9 Calibrated model predictions for 𝑘 = 400 
 
 Figure 5-8 and Figure 5-9 illustrate the coverage obtained from the calibrated model’s 
predictions for lower and higher values of the virus generation rate parameter, respectively. It is seen 
that by decreasing the virus generation rate, the prediction plots have higher uncertainty, while the 
increased parameter plots show narrower variance with some missed points at the peak. In addition, 
continuously reducing the virus generation rate led to unstable predictions (see Figure 5-10), as the 
virus balance resulted in an unrealistic suppression of the virus that is not expected unless some form 
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of drug therapy is used, and this would require a different model. These results show that the 
calibrated model can only be used to make predictions within a certain range, which can be defined 
by the reproductive ratio of infection as 𝑅0 > 1. For the case of HIV, as mentioned in Chapter 2, 
𝑅0 = 8 for the reference parameter values used. 
 
 
Figure 5-10 Unstable MCMC calibration predictions for 𝑘 = 10  
 
 The parameter bivariate contour plots (Figure 5-11) are generated for two additional starting 
points from Table 5-2 (GA#1 and GA#2) to determine the parameter coverage and 
calibration/predictions of different MCMC runs. These results show how the batch means criteria 
converged calibrations reach different Posterior distributions. 
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Figure 5-11 Bivariate contour plots for GA#1 (top) and GA#2 (bottom) 
 
 The previous plots show that each MCMC run reaches a significantly different empirical 
posterior pdf. Although this is not the desired convergence behavior that was initially anticipated, the 
following calibration (Figure 5-12) and prediction (Figure 5-13 and Figure 5-14) plots demonstrate 
that the distributions obtained are nonetheless useful for this virus model problem.  
 
 
Figure 5-12 MCMC calibrated model coverage for GA#1 (left) and GA#2 (right) 
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Figure 5-13 Calibrated model predictions for GA#1 (left) and GA#2 (right) with 𝑘 = 50 
 
 
Figure 5-14 Calibrated model predictions for GA#1 (left) and GA#2 (right) with 𝑘 = 400 
 
 The results for repeatedly different MCMC runs indicate that obtaining a statistically 
comparable (converged) empirical Posterior for every run was not possible with the configuration 
used. Figure 5-15 has the different Posterior PDFs obtained from the previous results, overlapped to 
show the areas where each MCMC run covered the same parameter space. The noise variance, 
parameter identifiability, and limited experimental data-type used (only measured virus, as opposed 
to including infected/uninfected cell counts) can be potential reasons for not being able to always 
obtain a fully converged Posterior. These results open the doorway to new opportunities to test the 
MCMC, using different configurations that may result in better Posterior convergence. Nonetheless, 
the calibrated model predictions obtained in this study show that Bayesian analysis can be effectively 
used to study multi-parameter dynamic models, such as this primary HIV model, and obtain useful 
predictions.  
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Figure 5-15 Overlapped parameter Posterior PDFs for GA#1, GA#2, and GA#5 
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Chapter 6  
Conclusions 
The MCMC calibration results demonstrate that Bayesian analysis is a promising alternative to 
conventional parameter estimation techniques that can be structured for multidimensional problems. 
Nevertheless, the results also indicate that the MCMC Bayesian calibration tool is difficult to 
completely automate and, in general, requires some level of adequate user input and experience to 
properly tune the simulation parameters.  
 
As was mentioned in earlier studies, the virus model’s parameter identifiability, although 
mathematically possible, is not guaranteed when only measured virus data is used. This statement 
was confirmed in this study, as coverage of all parameters in a single MCMC run was rarely obtained, 
even when using starting points close to the true values. Imposing certain parameter restrictions and 
assumptions such as a time invariant uninfected cell replenishment rate can lead to fixed parameters 
for this problem and a potentially simpler parameter estimation problem. This assumption is not easily 
implemented as only measured virus data is used. An alternative solution is to possibly repeat a virus 
model MCMC calibration run using additional data from the uninfected CD4 cell population.  
 
Although the true parameter values do not fall into regions of high marginal probability 
posterior density, the predictions from the calibrated model show coverage of the actual dynamic 
behavior for ranges outside of the calibration data, as was observed for a fixed virus generation rate 
parameter. Another problem occasionally encountered during the different calibrations was poor 
chain movement/coverage, most probably caused by a narrow parameter proposal distribution from 
a fixed covariance matrix. This issue could be solved by resetting the covariance matrix at the current 
MCMC step, but this has the unwanted consequence of requiring the user to closely monitor the 
chain’s progression to detect chain stagnation or flatline behavior. 
 
From this study, it can be concluded that Bayesian techniques can be successfully and 
usefully applied for modeling problems concerned with analyzing and calibrating noisy data sets. 
Additionally, Bayesian techniques offer an alternative solution to conventional gradient-based 
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estimation methods that cannot accurately fit noisy data, at the cost of more computational calibration 
time. Because computation time is a main concern and usually a key disadvantage of Bayesian 
calibration techniques, some possible solutions include MCMC parallelization and multiple moving 
chain algorithms that can simultaneously make several random walks from different starting points. 
 
From the results obtained in this thesis, some final comments and suggestions for future 
research are: as mentioned in other studies, using not only measured virus data, but also target cell 
population counts allows for better identification of the model parameters. A comparison of 
calibration results using both data sets may allow the MCMC to get better coverage of the true 
parameter values. Additionally, varying the measurement time sampling can account for more 
realistic infected patient HIV data. In actual patient measurements, the measured virus is sampled 
more frequently during primary infection to cover the infection’s characteristic peak behavior. 
Conversely, the initial data is rarely sampled and similarly the asymptotic phase offers almost no 
useful parameter identifiability. An interesting comparison is to rerun the MCMC with patient data 
only for the measured virus peak with a higher sampling frequency and also changing the variance in 
the added noise to have higher/lower experimental measurement variance. 
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